Before issuing the Emergency Use Authorization (EUA), the FDA reviewed data from large-scale clinical trials to ensure that the Novavax vaccine is safe and effective. The manufacturer of Novavax is also continuing to obtain additional data about the vaccine’s safety and effectiveness from ongoing clinical trials. Once these trials conclude, the FDA will determine whether to grant full approval for Novavax.
It's important to note that while efforts have been made to ensure the information is factually correct, comprehensive, and up to date, this should not replace the advice of a licensed healthcare professional. Always consult a doctor or healthcare professional before taking any medication. The drug information provided is subject to change and does not cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.
